(-)clausenamide improves long-term potentiation impairment and attenuates apoptosis after transient middle cerebral artery occlusion in rats

Neurological Research

Volumn 25, Issue 7, 2003, Pages 713-717

  Tang, Kang ^a   Zhang, Jun Tian ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

( )clausenamide; Apoptosis; Cerebral ischemia; Long term potentiation; Mitochondrial viability

Indexed keywords

CLAUSENAMIDE; RHODAMINE 123;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DNA DAMAGE; LONG TERM POTENTIATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NICK END LABELING; NONHUMAN; RAT; REPERFUSION;

ANIMALS; APOPTOSIS; DRUGS, CHINESE HERBAL; INFARCTION, MIDDLE CEREBRAL ARTERY; LACTAMS; LIGNANS; LONG-TERM POTENTIATION; MALE; RATS; RATS, WISTAR;

EID: 0142121560     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101202219     Document Type: Article

References (18)

1. Dimagl U, Iadecola C, Moskowits MA. Pathobiology of ischemic stroke: An integrated view. Trends Neurosci 1999; 22: 391-397
2. Liu SL, Zhang JT. difference between the effects of (-)clausenamide and (+)clausenamide of the synaptic transmission in the dentate gyrus of anesthetized rats. Acta Pharm Sin 1998; 33: 254-258
3. Liu SL, Zhao MR, Zhang JT. Effects of clausenamide on synaptic transmission of the dentate gyrus in freely-moving rats. Acta Pharm Sin 1999; 325-328
4. Tang K, Zhang J. The effects of (-)clausenamide on functional recovery in transient focal cerebral ischemia. Neurol Res 2002; 24: 473-478
5. Aoyagi A, Saito H, Abe K, Nishiyama N. Early impairment and late recovery of synaptic transmission in the rat dentate gyrus following transient forebrain ischemia in vivo. Brain Res 1998; 799: 130-137
6. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem 1998; 252: 1-15
7. α high expressing PC12 cell line and the mechanisms of (-)clausenamide in inhibiting apoptosis. Acta Pharm Sion 2000; 35: 404-407
8. Longa ZE, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91
9. Gavrieli Y, Sherman Y, Ben-Sason SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 11: 493-501
10. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998; 18: 205-213
11. Bliss TV, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993; 361: 31-39
12. Okada M, Nakanishi H, Tamura A, Urae A, Mine K, Yamamoso K, Fujiwara M. Long-term spatial cognitive impairment after middle cerebral artery occlusion in rats: No involvement of the hippocampus. J Cereb Blood Flow Metab 1995; 15: 1012-1021
13. Wahl F, Allix M, Poltkine M, Boulu RG. Neurologcial and behavioral outcomes of focal cerebral ischemia in rats. Stroke 1992; 23: 267-272
14. Sopala M, Frankiewicz T, Parsons C, Danysz W. Middle cerebral artery occlusion produces secondary, remote impairment in hippocampal plasticity of rats - involvement of N-methyl-D-aspartate receptor? Neurosci Lett 2000; 281: 143-146
15. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 1996; 6: 667-672
16. Chopp M, Li Y. Apoptosis in focal cerebral ischemia. Acta Neurochir Suppl 1996; 66: 21-26
17. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by inhibition of apoptosis. Brain Pathol 2000; 10: 283-292
18. Schulz JB, Weller M, Marthews RT, Heneka MT, Groscurth P, Martinopu JC, Lommatzsch, von Coelln R, Wullner U, Loschmann PA, Beal MF, Dichgans J, Klochgether T. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ 1998; 5: 847-857